Recombinant activated factor VII (rFVIIa/NovoSeven) in intractable haemorrhage: use of a clinical scoring system to predict outcome.
about
Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published dataRecombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use.Blood loss and contributing factors in femoral fracture surgery.Controversies of anticoagulation reversal in life-threatening bleeds.Predicting response to recombinant activated factor VIIa administration in the critically ill.Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin.
P2860
Recombinant activated factor VII (rFVIIa/NovoSeven) in intractable haemorrhage: use of a clinical scoring system to predict outcome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Recombinant activated factor V ...... ing system to predict outcome.
@en
Recombinant activated factor VII
@nl
type
label
Recombinant activated factor V ...... ing system to predict outcome.
@en
Recombinant activated factor VII
@nl
prefLabel
Recombinant activated factor V ...... ing system to predict outcome.
@en
Recombinant activated factor VII
@nl
P2860
P1433
P1476
Recombinant activated factor V ...... ing system to predict outcome.
@en
P2093
P2860
P356
10.1111/J.1423-0410.2005.00711.X
P577
2006-01-01T00:00:00Z